Drug Database
Back to search

Netherlands· NL-e6099643ac09

Ampicilline/Sulbactam AptaPharma 2 g/1 g, poeder voor oplossing voor injectie/infusie

A ampicillin und beta-lactamase-inhibitor product containing ampicilline natrium + sulbactamnatrium, registered in Netherlands by Apta Medica Internacional d.o.o.. The same ATC class is registered in 6 of our 19 countries.

ATC J01CR01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAmpicilline/Sulbactam AptaPharma 2 g/…ATCJ01CR01REGISTER NO.NL-e6099643ac09PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ampicilline natrium + sulbactamnatriumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ampicillin und beta-lactamase-inhibitor is registered in 6 of 19 countries.

Countries holding a registration under ATC J01CR01 (ampicillin und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search ampicillin und beta-lactamase-inhibitor products by name

Ampicillin und beta-lactamase-inhibitor · ATC J01CR01

6 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AMPICILLINE NATRIUM + SULBACTAMNATRIUM
Manufacturer
Apta Medica Internacional d.o.o.
Country
Netherlands (NL)
ATC code
J01CR01
ATC class
Ampicillin und Beta-Lactamase-Inhibitor
Defined daily dose
6 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132361

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ampicillin und beta-lactamase-inhibitor in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ampicillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Ampicillin/Sulbactam Aptapharma, Unasyn
  • Bulgaria · Ампиплюс, Ампицилин/Сулбактам Аптафарма
  • Cyprus · Ampicillin/Sulbactam Aptapharma, Begalin-P
  • Czechia · Ampicillin And Sulbactam Ibi, Ampicillin/Sulbactam Aptapharma
  • Germany · Ampicillin Plus Sulbactam Eberth, Ampicillin Und Sulbactam Ibi
  • Denmark · Ampicillin/Sulbactam Aptapharma
  • Estonia · Ampicillin/Sulbactam Auxilia, Ampicillin/Sulbactam Bausch Health
  • Finland · Ampicillin/Sulbactam Aptapharma
  • France · Unacim Injectable
  • Greece · Begalin-P, Demotine
  • Croatia · Ampicilin/Sulbaktam Aptapharma
  • Hungary · Ampicillin/Sulbactam Aptapharma, Unasyn
  • Italy · Ampicillina E Sulbactam Ibi, Unasyn
  • Lithuania · Ampicillin/Sulbactam Auxilia
  • Malta · Ampicillin/Sulbactam Aptapharma
  • Norway · Ampicillin/Sulbactam Aptapharma
  • Poland · Ampicilin+sulbactam Aptapharma, Ampicillin Sulbactam Tzf
  • Portugal · Ampicilina/Sulbactam Reiwa Healthcare
  • Romania · Ampicilină/Sulbactam Aptapharma, Ampiplus
  • Sweden · Ampicillin/Sulbactam Aptapharma
  • Slovenia · Ampicilin/Sulbaktam Aptapharma
  • Slovakia · Ampicilín/Sulbaktám Aptapharma, Ampicillin/Sulbactam Bausch Health

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0526ec0-074c-4774-9052-944693b41124
GET /v1/drugs/e0526ec0-074c-4774-9052-944693b41124?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie of infusie",
  "route": "Intraveneus gebruik, Intramusculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132361_smpc.pdf",
  "strength": null,
  "atc_label": "Ampicillin and beta-lactamase inhibitor",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132361",
  "excipients": [
    "GEEN HULPSTOFFEN"
  ],
  "substances": [
    "AMPICILLINE NATRIUM",
    "SULBACTAMNATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132361.pdf",
  "authorised_at": "2024/05/08",
  "procedure_number": "SI/H/0222/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132361",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about ampicillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console